1. Home
  2. JAGX vs EDBL Comparison

JAGX vs EDBL Comparison

Compare JAGX & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • EDBL
  • Stock Information
  • Founded
  • JAGX 2013
  • EDBL 2020
  • Country
  • JAGX United States
  • EDBL United States
  • Employees
  • JAGX N/A
  • EDBL N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • EDBL Farming/Seeds/Milling
  • Sector
  • JAGX Health Care
  • EDBL Consumer Staples
  • Exchange
  • JAGX Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • JAGX 3.9M
  • EDBL 4.0M
  • IPO Year
  • JAGX N/A
  • EDBL 2022
  • Fundamental
  • Price
  • JAGX $1.28
  • EDBL $1.17
  • Analyst Decision
  • JAGX Strong Buy
  • EDBL
  • Analyst Count
  • JAGX 1
  • EDBL 0
  • Target Price
  • JAGX $60.00
  • EDBL N/A
  • AVG Volume (30 Days)
  • JAGX 111.9K
  • EDBL 71.7K
  • Earning Date
  • JAGX 11-17-2025
  • EDBL 11-14-2025
  • Dividend Yield
  • JAGX N/A
  • EDBL N/A
  • EPS Growth
  • JAGX N/A
  • EDBL N/A
  • EPS
  • JAGX N/A
  • EDBL N/A
  • Revenue
  • JAGX $11,785,000.00
  • EDBL $12,553,000.00
  • Revenue This Year
  • JAGX $22.41
  • EDBL $29.56
  • Revenue Next Year
  • JAGX $30.00
  • EDBL $20.00
  • P/E Ratio
  • JAGX N/A
  • EDBL N/A
  • Revenue Growth
  • JAGX 12.45
  • EDBL N/A
  • 52 Week Low
  • JAGX $1.10
  • EDBL $1.05
  • 52 Week High
  • JAGX $33.25
  • EDBL $13.50
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 32.53
  • EDBL 36.33
  • Support Level
  • JAGX $1.10
  • EDBL $1.05
  • Resistance Level
  • JAGX $1.98
  • EDBL $1.25
  • Average True Range (ATR)
  • JAGX 0.20
  • EDBL 0.12
  • MACD
  • JAGX -0.04
  • EDBL -0.00
  • Stochastic Oscillator
  • JAGX 19.00
  • EDBL 33.12

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: